Summary

Persistence Market Research has recently published an extensive report on the global Interventional Oncology Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Interventional Oncology Market Size (2024E): USD 2.1 Bn
• Projected Market Value (2031F): USD 3.5 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 8.1%

Interventional Oncology Market - Report Scope:

The Interventional Oncology Market encompasses a range of minimally invasive techniques, such as radiofrequency ablation, cryoablation, and transarterial chemoembolization, designed to treat cancer effectively with reduced patient discomfort. These treatments are gaining traction as they provide targeted therapy with improved safety compared to traditional surgery. The market’s expansion is driven by the rising prevalence of cancer globally, coupled with innovations in imaging technologies and device development, which enhance treatment precision and patient outcomes.

Market Growth Drivers:

The global Interventional Oncology Market is propelled by several factors, including the increasing prevalence of cancer and the growing demand for minimally invasive treatments. Techniques such as radiofrequency ablation and cryoablation offer less invasive alternatives to traditional surgeries, improving recovery times and minimizing complications. The ongoing development of advanced imaging tools, like MRI and CT scans, further enhances these procedures' accuracy, fostering market growth. Additionally, the focus on cost-effective, patient-centered care is driving innovations in sedation techniques, pain management, and monitoring technologies, contributing to a better overall experience during interventional procedures.

Market Restraints:

Despite the potential for growth, the Interventional Oncology Market faces significant challenges. Limited access to advanced interventional treatments in low- and middle-income countries hampers market expansion. Inadequate healthcare infrastructure, a shortage of specialized equipment, and trained professionals prevent widespread adoption of innovative treatments in these regions. Furthermore, the high cost of these procedures remains a barrier to entry in price-sensitive markets. Addressing these disparities in access to care is crucial to the market's future growth.

Market Opportunities:

The Interventional Oncology Market presents substantial opportunities, particularly in North America, where the market is expected to expand at a CAGR of 8.3% through 2031. Innovations in device technology, combined with a growing focus on personalized and precision medicine, offer tremendous growth potential. The increasing adoption of minimally invasive cancer treatments in emerging markets, supported by expanding healthcare infrastructure and growing awareness, also represents a key growth area. Furthermore, the rise of e-commerce and direct-to-consumer sales channels enhances accessibility to interventional oncology devices, expanding their use beyond traditional healthcare settings.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Interventional Oncology Market globally?
• Which interventional oncology techniques are leading the market in terms of adoption and effectiveness?
• How are advancements in imaging technologies influencing the competitive landscape of the Interventional Oncology Market?
• Who are the key players in the Interventional Oncology Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Interventional Oncology Market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Interventional Oncology Market are focusing on innovation, product differentiation, and strategic collaborations to maintain their competitive edge. Investments in R&D, particularly in the development of advanced ablation devices and imaging tools, are crucial to staying ahead in this rapidly evolving market. Partnerships with hospitals and healthcare providers are also key to expanding market reach and promoting the adoption of new products. Marketing strategies that emphasize the benefits of minimally invasive treatments and advanced imaging technologies help drive consumer interest and foster brand loyalty.

Key Market Players

• Profound Medical
• Medtronic Plc.
• Hologic, Inc.
• Boston Scientific Corporation
• AngioDynamics
• Terumo Corporation
• Teleflex Incorporated
• Alpinion Medical Systems Co. Ltd.
• Siemens Healthineers
• Merit Medical


Interventional Oncology Industry Segmentation

By Product

• Radiation Therapy Devices
• Ablation Devices
• Embolization Devices

By Cancer Type

• Lung Cancer
• Liver Cancer
• Kidney Cancer
• Others

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centre

By Region

• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• Latin America

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Interventional Oncology Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Interventional Oncology Market Outlook: Product
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
4.3.3.1. Radiation Therapy Devices
4.3.3.2. Ablation Devices
4.3.3.2.1. Microwave ablation
4.3.3.2.2. Radiofrequency ablation
4.3.3.2.3. Cryoablation
4.3.3.2.4. Others
4.3.3.3. Embolization Devices
4.3.3.3.1. Microcatheters
4.3.3.3.2. Guidewires
4.4. Market Attractiveness Analysis: Product
4.5. Global Interventional Oncology Market Outlook: Cancer Type
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Cancer Type, 2019-2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
4.5.3.1. Lung Cancer
4.5.3.2. Liver Cancer
4.5.3.3. Kidney Cancer
4.5.3.4. Others
4.6. Market Attractiveness Analysis: Cancer Type
4.7. Global Interventional Oncology Market Outlook: End User
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
4.7.3.1. Hospitals
4.7.3.2. Specialty Clinics
4.7.3.3. Ambulatory Surgical Center
4.7.3.4. Others
4.8. Market Attractiveness Analysis: End User
5. Global Interventional Oncology Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
6.2.1. By Country
6.2.2. By Product
6.2.3. By Cancer Type
6.2.4. By Route of Administration
6.2.5. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
6.4.1. Radiation Therapy Devices
6.4.2. Ablation Devices
6.4.2.1. Microwave ablation
6.4.2.2. Radiofrequency ablation
6.4.2.3. Cryoablation
6.4.2.4. Others
6.4.3. Embolization Devices
6.4.3.1. Microcatheters
6.4.3.2. Guidewires
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
6.5.1. Lung Cancer
6.5.2. Liver Cancer
6.5.3. Kidney Cancer
6.5.4. Others
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
6.6.1. Hospitals
6.6.2. Specialty Clinics
6.6.3. Ambulatory Surgical Center
6.6.4. Others
6.7. Market Attractiveness Analysis
7. Europe Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
7.2.1. By Country
7.2.2. By Product
7.2.3. By Cancer Type
7.2.4. By Route of Administration
7.2.5. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Turkey
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
7.4.1. Radiation Therapy Devices
7.4.2. Ablation Devices
7.4.2.1. Microwave ablation
7.4.2.2. Radiofrequency ablation
7.4.2.3. Cryoablation
7.4.2.4. Others
7.4.3. Embolization Devices
7.4.3.1. Microcatheters
7.4.3.2. Guidewires
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
7.5.1. Lung Cancer
7.5.2. Liver Cancer
7.5.3. Kidney Cancer
7.5.4. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
7.6.1. Hospitals
7.6.2. Specialty Clinics
7.6.3. Ambulatory Surgical Center
7.6.4. Others
7.7. Market Attractiveness Analysis
8. East Asia Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
8.2.1. By Country
8.2.2. By Product
8.2.3. By Cancer Type
8.2.4. By Route of Administration
8.2.5. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
8.4.1. Radiation Therapy Devices
8.4.2. Ablation Devices
8.4.2.1. Microwave ablation
8.4.2.2. Radiofrequency ablation
8.4.2.3. Cryoablation
8.4.2.4. Others
8.4.3. Embolization Devices
8.4.3.1. Microcatheters
8.4.3.2. Guidewires
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
8.5.1. Lung Cancer
8.5.2. Liver Cancer
8.5.3. Kidney Cancer
8.5.4. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
8.6.1. Hospitals
8.6.2. Specialty Clinics
8.6.3. Ambulatory Surgical Center
8.6.4. Others
8.7. Market Attractiveness Analysis
9. South Asia & Oceania Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
9.2.1. By Country
9.2.2. By Product
9.2.3. By Cancer Type
9.2.4. By Route of Administration
9.2.5. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
9.4.1. Radiation Therapy Devices
9.4.2. Ablation Devices
9.4.2.1. Microwave ablation
9.4.2.2. Radiofrequency ablation
9.4.2.3. Cryoablation
9.4.2.4. Others
9.4.3. Embolization Devices
9.4.3.1. Microcatheters
9.4.3.2. Guidewires
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
9.5.1. Lung Cancer
9.5.2. Liver Cancer
9.5.3. Kidney Cancer
9.5.4. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
9.6.1. Hospitals
9.6.2. Specialty Clinics
9.6.3. Ambulatory Surgical Center
9.6.4. Others
9.7. Market Attractiveness Analysis
10. Latin America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
10.2.1. By Country
10.2.2. By Product
10.2.3. By Cancer Type
10.2.4. By Route of Administration
10.2.5. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
10.4.1. Radiation Therapy Devices
10.4.2. Ablation Devices
10.4.2.1. Microwave ablation
10.4.2.2. Radiofrequency ablation
10.4.2.3. Cryoablation
10.4.2.4. Others
10.4.3. Embolization Devices
10.4.3.1. Microcatheters
10.4.3.2. Guidewires
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
10.5.1. Lung Cancer
10.5.2. Liver Cancer
10.5.3. Kidney Cancer
10.5.4. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
10.6.1. Hospitals
10.6.2. Specialty Clinics
10.6.3. Ambulatory Surgical Center
10.6.4. Others
10.7. Market Attractiveness Analysis
11. Middle East & Africa Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
11.2.1. By Country
11.2.2. By Product
11.2.3. By Cancer Type
11.2.4. By Route of Administration
11.2.5. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
11.4.1. Radiation Therapy Devices
11.4.2. Ablation Devices
11.4.2.1. Microwave ablation
11.4.2.2. Radiofrequency ablation
11.4.2.3. Cryoablation
11.4.2.4. Others
11.4.3. Embolization Devices
11.4.3.1. Microcatheters
11.4.3.2. Guidewires
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
11.5.1. Lung Cancer
11.5.2. Liver Cancer
11.5.3. Kidney Cancer
11.5.4. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
11.6.1. Hospitals
11.6.2. Specialty Clinics
11.6.3. Ambulatory Surgical Center
11.6.4. Others
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Profound Medical
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Medtronic Plc.
12.3.3. Hologic, Inc.
12.3.4. Boston Scientific Corporation
12.3.5. AngioDynamics
12.3.6. Terumo Corporation
12.3.7. Teleflex Incorporated
12.3.8. Alpinion Medical Systems Co. Ltd.
12.3.9. Siemens Healthineers
12.3.10. Merit Medical
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations